According to FutureWise analysis the Opioid Dependence Treatment Market in 2025 is US$ 3.36 billion, and is expected to reach US$ 7.45 billion by 2033 at a CAGR of 10.47%. The growth in opioid misuse treatment stems from increased awareness, better access to medication-assisted treatment (MAT), and the rising use of buprenorphine and methadone. Government initiatives and telehealth expansion also enhance treatment outcomes globally.
Opioid dependence encompasses elements of opioid addiction and opioid use disorder. Treatment for opioid drug addiction is provided in various settings and employs a combination of behavioral and pharmacological approaches. Current treatments focus on maintenance therapy using medications such as buprenorphine, methadone (an opioid agonist), and naltrexone (an opioid antagonist). Additionally, naloxone is utilized as a rescue medication in the event of an overdose, and it may also be used alongside buprenorphine in certain cases.
Opioid dependence has a chronic impact on the social well-being and economic conditions of those affected. The changing patterns in life sciences and the increased use of narcotics for pain management are significant contributors to opioid dependency. Furthermore, the growing prevalence of opioid addiction worldwide has accelerated market growth. According to the US National Institutes of Health, opioid dependency affects approximately 2 million people in the United States and 15 million globally. In 2016, more than 35,000 deaths were attributed to the misuse of opioids.
Currently available treatment options focus on detoxification and long-term maintenance using agonist therapies. Research indicates that pharmacological therapies are more effective than alternative treatments, which has contributed to market growth. Furthermore, the increasing reliance on pharmacological therapies by healthcare professionals is expected to boost demand during the forecast period.
AI Integration: Over 30% of opioid treatment programs are now using AI tools to improve treatment outcomes and reduce relapse, signifying a major shift towards personalized and data-driven care.
FutureWise Market Research has published a report that provides an insightful analysis of Opioid Dependence Treatment Market trends that are affecting the overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=207&type=requestsample
Opioid Dependence Treatment Market Segmentation:
By Drug Class
• Buprenorphine
• Naloxone
• Methadone

By Sales Channel
• Retail Pharmacies
• Hospitals
• Rehabilitation Centres


By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Opioid Dependence Treatment Market:
• Reckitt Benckiser Pharmaceuticals Inc.
• Mylan
• Dr. Reddy's Laboratories
• ADAPT Pharma, Inc.
• LUMITOS AG

Recent developments by key players in Opioid Dependence Treatment :

Mylan (Viatris)
Viatris, formerly known as Mylan, has reached a nationwide multistate settlement worth up to $335 million over nine years to address legal claims related to opioids. The company will make annual payments ranging from approximately $27.5 million to $40 million to support state and local initiatives focused on responding to the opioid crisis.

Dr. Reddy's Laboratories
• Dr. Reddy’s relaunched its generic buprenorphine/naloxone sublingual film (equivalent to Suboxone) in the U.S. in February 2019 after a favorable appellate decision lifted an injunction that had previously blocked sales. The firm originally launched "at-risk" in June 2018 before facing legal setbacks.
• In June 2022, Dr. Reddy's reached a settlement with Indivior and Aquestive, resolving all patent and antitrust claims. The agreement led to the dismissal of all pending cases and included a payment arrangement totaling $72 million to be completed by March 2024.


Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=207&license=multi


**Objectives of this Study: **
1. To provide a comprehensive analysis of the Opioid Dependence Treatment Market By Drug Class, by Sales Channel and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: [email protected]

FutureWise Research
Contact Person: Vinay Thaploo.
Email: [email protected]
Contact Number: Asia: +91 8605575209 | UK: +44 0113 519 7222
Website: www.futurewiseresearch.com